MedTrace Logo

Evaluation of Egg Consumption and Its Enrichment With Annatto on Cardiovascular Risk and Satiety in Healthy Adults

NCT05088577 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 105

Last updated 2021-10-29

No results posted yet for this study

Summary

Healthy adult volunteers (n= 105; 18-59 years) were randomly allocated to consume daily for 8 weeks, either two whole eggs (egg group), two whole eggs added with annatto (annatto-enriched egg group), or two egg whites (control). Volunteers were asked to continue with the habitual physical activity and diet, except for the consumption of additional eggs, egg whites or annatto.

It is hypothesized that participants consuming eggs would have a less atherogenic lipid profile, feel more satisfied and increase antioxidant levels in blood, compared to the control group. Participants in the annatto-enriched egg group would have greater antioxidant capacity than the egg group and compared to control.

Conditions

  • Healthy Volunteers

Interventions

DIETARY_SUPPLEMENT

Whole egg

Daily consumption of two whole eggs during 8 weeks

DIETARY_SUPPLEMENT

Annatto-enriched egg

Daily consumption of two whole eggs enriched with annatto during 8 weeks

DIETARY_SUPPLEMENT

Egg whites - Control

Daily consumption of two eggs whites during 8 weeks

Sponsors & Collaborators

  • Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnología (COLCIENCIAS)

    collaborator OTHER_GOV

  • Universidad de Antioquia

    lead OTHER

Principal Investigators

  • Jacqueline Barona-Acevedo, PhD · Universidad de Antioquia

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
59 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-10-11
Primary Completion
2020-12-18
Completion
2020-12-18

Countries

  • Colombia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05088577 on ClinicalTrials.gov